Other OTC Pharmaceuticals - Ivory Coast

  • Ivory Coast
  • In 2024, the revenue generated in the Other OTC Pharmaceuticals market in Ivory Coast amounts to US$13.13m.
  • It is projected that this market will experience an annual growth rate of 2.19% (CAGR 2024-2029).
  • When compared to other countries globally, the in the United States generates the highest revenue in this market, reaching US$7,171.00m in 2024.
  • In terms of per capita revenue, in Ivory Coast generates US$0.44 per person in 2024.
  • In Ivory Coast, the trend in the Other OTC Pharmaceuticals market is a growing demand for traditional herbal remedies.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Ivory Coast is experiencing steady growth due to increasing customer preferences for self-medication, rising healthcare awareness, and the availability of a wide range of OTC products.

Customer preferences:
In Ivory Coast, customers are increasingly opting for self-medication as a convenient and cost-effective solution for minor health issues. This preference is driven by the ease of access to OTC pharmaceutical products, which can be purchased without a prescription. Additionally, the growing healthcare awareness among the population has led to an increased demand for OTC products, as people are becoming more proactive in managing their own health.

Trends in the market:
The Other OTC Pharmaceuticals market in Ivory Coast is witnessing several trends that are driving its growth. Firstly, there is a growing demand for analgesics and cold/flu remedies, as these are common health issues that people seek relief from without visiting a healthcare professional. Secondly, there is an increasing trend of using herbal and natural remedies, as customers are becoming more conscious about the potential side effects of synthetic medications. This has led to the introduction of a wide range of herbal and natural OTC products in the market. Additionally, there is a rising trend of online purchasing of OTC products, as customers are seeking convenience and a wider product selection.

Local special circumstances:
Ivory Coast has a large rural population, and access to healthcare facilities can be limited in these areas. This has further fueled the demand for OTC pharmaceutical products, as people often rely on self-medication to manage their health issues. Furthermore, the country has a growing middle class with increasing disposable income, which has contributed to the affordability of OTC products for a larger portion of the population.

Underlying macroeconomic factors:
The Ivory Coast economy has been experiencing steady growth in recent years, which has positively impacted the purchasing power of the population. This economic growth has led to an increase in disposable income, allowing more people to afford OTC pharmaceutical products. Additionally, the government has been investing in healthcare infrastructure and promoting healthcare awareness, which has further contributed to the growth of the OTC Pharmaceuticals market.In conclusion, the Other OTC Pharmaceuticals market in Ivory Coast is witnessing steady growth due to increasing customer preferences for self-medication, rising healthcare awareness, and the availability of a wide range of OTC products. The trends in the market, such as the demand for analgesics and cold/flu remedies, the use of herbal and natural remedies, and the rise of online purchasing, are driving the market growth. The local special circumstances, including limited access to healthcare facilities in rural areas and a growing middle class with increasing disposable income, are further contributing to the market's development. The underlying macroeconomic factors, such as the country's economic growth and government investments in healthcare infrastructure, are also playing a significant role in the market's expansion.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)